Skip to main navigation Skip to search Skip to main content

Central role of hemoglobin degradation in mechanisms of action of 4- aminoquinolines, quinoline methanols, and phenanthrene methanols

  • Mathirut Mungthin
  • , Patrick G. Bray
  • , Robert G. Ridley
  • , Steve Ward
  • University of Liverpool
  • F. Hoffmann-La Roche AG

Research output: Contribution to journalArticlepeer-review

89 Citations (Scopus)

Abstract

We have used a specific inhibitor of the malarial aspartic proteinase plasmepsin I and a nonspecific cysteine proteinase inhibitor to investigate the importance of hemoglobin degradation in the mechanism of action of chloroquine, amodiaquine, quinine, mefloquine (MQ), halofantrine, and primaquine. Both proteinase inhibitors antagonized the antiparasitic activity of all drugs tested with the exception of primaquine. An inhibitor of plasmepsin I, Ro40-4388, reduced the incorporation of radiolabelled chloroquine and quinine into malarial pigment by 95%, while causing a 70% reduction in the incorporation of radiolabelled MQ. Cysteine proteinase inhibitor E64 reduced the incorporation of chloroquine and quinine into malarial pigment by 60 and 40%, respectively. This study provides definitive support for the central role of hemoglobin degradation in the mechanism of action of the 4-aminoquinolines and the quinoline and phenanthrene methanol antimalarials.
Original languageEnglish
Pages (from-to)2973-2977
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume42
Issue number11
DOIs
Publication statusPublished - 1 Nov 1998
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Central role of hemoglobin degradation in mechanisms of action of 4- aminoquinolines, quinoline methanols, and phenanthrene methanols'. Together they form a unique fingerprint.

Cite this